Read + Share
Amedeo Smart
Independent Medical Education
van Dijk MJ, Rab MAE, van Oirschot BA, Bos J, et al. Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study. Am J Hematol 2022;97:E226-E229.PMID: 35384026
Email
LinkedIn
Facebook
Twitter
Privacy Policy